Ivermectin Dose For Lyme Disease

What Is The Treatment

Most cases of Lyme disease can be effectively treated with 2 to 4 weeks of antibiotics. Depending on the symptoms and when you were diagnosed, you may require a longer course or repeat treatment with antibiotics.

Some people experience symptoms that continue more than 6 months after treatment. Research continues into the causes of these persistent symptoms and possible treatment methods.

Malaria Treatment And Chemoprophylaxis

Doxycycline is used for both treatment and chemoprophylaxis of malaria. Both Plasmodium falciparum and Plasmodium vivax are susceptible to doxycycline. Along with atovaquone-proguanil and artemisinin compounds, the combination of quinine and doxycycline is recommended for treatment of chloroquine-resistant P. falciparum strains.141 Doxycycline is less often used to treat P. vivax infections due to its slower rate of parasitic clearance and limited activity in the liver stages compared with other regimens.142

As for chemoprophylaxis, doxycycline has been shown to be as effective as mefloquine in regions with chloroquine-resistant P. falciparum. In two studies, doxycycline was protective in 99% to 100% of participants, although mefloquine was better tolerated in one study.143,144 Other studies have shown malaria develop in those taking doxycycline prophylaxis who ended therapy shortly after leaving an endemic area, likely due to the fact that doxycycline has limited effect on pre-erythrocytic liver stages of malaria.145-148 On the basis of these studies, it is recommended that doxycycline be taken for 4 weeks after returning from an endemic area.149

Patricia Schlagenhauf, … Lin H. Chen, in, 2019

Developing Ivermectin For Human Use

Early experiments by William Campbell and his team from Merck discovered that the drug also worked against a human parasite that causes an infection called river blindness.

River blindness, also known as onchocerciasis, is the second leading cause of preventable blindness in the world. It is transmitted to humans from blackflies carrying the parasitic worm Onchocerca volvulus and occurs predominantly in Africa.

Ivermectin underwent trials to treat river blindness in 1982 and was approved in 1987. It has since been distributed free of charge through the Mectizan Donation Program to dozens of countries. Thanks to ivermectin, river blindness has been essentially eliminated in 11 Latin American countries, preventing approximately 600,000 cases of blindness.

These two decades of extensive work to discover, develop and distribute ivermectin helped to significantly reduce human suffering from river blindness. Its these efforts that were recognized by the 2015 Nobel Prize in Physiology or Medicine, awarded to both William Campbell and Satoshi Omura for their leadership on this groundbreaking research.

Also Check: Lyme Disease And Red Meat

What Are The Side Effects Of Lyme Disease Treatments

Antibiotics, like all medications, have the potential for side effects. Any antibiotic can cause skin rashes, and if an itchy red rash develops while on antibiotics, a patient should see their physician. Sometimes symptoms worsen for the first few days on an antibiotic. This is called a Herxheimer reaction and occurs when the antibiotics start to kill the bacteria. In the first 24 to 48 hours, dead bacterial products stimulate the immune system to release inflammatory cytokines and chemokines that can cause increased fever and achiness. This should be transient and last no more than a day or two after the initiation of antibiotics.

The most common side effect of the penicillin antibiotics is diarrhea, and occasionally even serious cases caused by the bacteria Clostridium difficile. This bacterial overgrowth condition occurs because antibiotics kill the good bacteria in our gut. It can be helpful to use probiotics to restore the good bacteria and microbiome balance.

Disulfirambreakthrough Drug For Lyme And Other Tick

I have been practicing medicine long enough to be very skeptical of breakthroughs. But disulfiram may be the real thing. Lets keep our fingers crossed.

Anyone who reads the financial pages has heard of Steven Cohen, the multi-billionaire hedge fund manager and philanthropist. Cohen lives in Connecticut where his wife, Alexandra, became ill with Lyme disease.

The Cohens established the Cohen Lyme and Tick-borne Disease Initiative, a division within their philanthropic organization focused on supporting Lyme and tick-borne disease research. The Steven and Alexandra Cohen Foundation has committed over $60 million dollars to support more than 25 Lyme disease research projects.

In 2016, the Cohen Foundation sponsored the first annual Lyme Disease in the Era of Precision Medicine Conference at the Mount Sinai School of Medicine in New York.

Those of us who actually treat Lyme disease know there is nothing precise about it. Treating chronic infection with Borrelia burgdorferi, complicated by any number of co-infections, is often hit or miss. Nevertheless, we who practice where the rubber meets the road are grateful for whatever clues basic researchers provide that can help our patients.

Recommended Reading: Old Lyme Homes For Sale

Candida And Fungal Infections

Candida syndrome with intestinal dysbiosis is not an uncommon health problem. It should be suspected in any MSIDS patient who has unexplained fatigue, joint and muscle pain, and neurological symptoms such as brain fog and headaches that are unresponsive or worsen with standard treatment regimens.

I first learned about candida many years ago after one of my patients had developed a strange set of skin rashes that worsened every time she took antibiotics. She also complained of chronic fatigue, headaches, blood sugar swings, trouble concentrating, and digestive problems. In searching for answers, I came across William Crooks book, The Yeast Connection. In it he described my patients symptoms perfectly. By placing her on a yeast-free diet and treating the candida with antifungal agents, we were able to reverse all of her symptoms, which had baffled dermatologists and other subspecialists who had been unable to find a cause.

Although we normally have candida organisms present in our gastrointestinal tract in limited amounts, taking antibiotics for bacterial infections will encourage an overgrowth of candida.

Antibiotics kill off the good bacteria that keep our normal level of yeast in check. Furthermore, the standard American diet, which is high in sugar and refined carbohydrates, can promote an overgrowth of yeast. Other factors that may contribute to the candida syndrome are:

Treating Candida and Yeast Infections

Pregnancy Breastfeeding & Lyme Bibliography

Any woman who has Lyme disease and is considering becoming pregnant or who is pregnant, or who is bitten by a tick during pregnancy, should see a Lyme disease doctor, one who understands the serious medical implications of Lyme during pregnancy. The Lyme bacteria, Borrelia burgdorferi, can cross the placenta and can cause death of the fetus. The Lyme Disease Association has compiled the following list of articles related to Lyme and pregnancy and Lyme and breastfeeding for informational purposes only, for your review and review by your physician.

Project Lyme & Mothers Against Lyme Webinar Lyme Disease & Pregnancy: State of the Science & Opportunities for Researchfeaturing Holly Ahern, MS, MT , Sue Faber, RN, BScN, & Representatives from the NIH.

Read Also: Lyme Disease Symptoms And Treatment

Treatment For Erythema Migrans

People treated with appropriate antibiotics in the early stages of Lyme disease usually recover rapidly and completely. Early diagnosis and proper antibiotic treatment of Lyme disease can help prevent late Lyme disease.

Treatment regimens listed in the following table are for the erythema migrans rash, the most common manifestation of early Lyme disease. These regimens may need to be adjusted depending on a persons age, medical history, underlying health conditions, pregnancy status, or allergies. Consult an infectious disease specialist regarding individual patient treatment decisions.

Treatment regimens for localized Lyme disease.

Age Category
100 mg, twice per day orally	N/A
500 mg, three times per day orally	N/A
500 mg, twice per day orally	N/A
4.4 mg/kg per day orally, divided into 2 doses	100 mg per dose
50 mg/kg per day orally, divided into 3 doses	500 mg per dose
30 mg/kg per day orally, divided into 2 doses	500 mg per dose

*When different durations of antibiotics are shown to be effective for the treatment of Lyme disease, the shorter duration is preferred to minimize unnecessary antibiotics that might result in adverse effects, including infectious diarrhea and antimicrobial resistance.

NOTE: For people intolerant of amoxicillin, doxycycline, and cefuroxime, the macrolide azithromycin may be used, although it is less effective. People treated with azithromycin should be closely monitored to ensure that symptoms resolve.

Before Taking This Medicine

You should not use ivermectin if you are allergic to it.

To make sure ivermectin is safe for you, tell your doctor if you have:

• liver or kidney disease or

• cancer, HIV or AIDS, or other conditions that can weaken your immune system.

It is not known whether ivermectin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

Ivermectin can pass into breast milk and may harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Ivermectin should not be given to a child who weighs less than 33 pounds .

Don’t Miss: Dr Emilia Eiras Lyme Disease

Cytotoxicity Assay Of Ivm On Hff Mdbk And Nih/3t3 Cell Lines

The drug-exposure viability assay was performed in accordance with the protocol described previously . Briefly, 100 L of cells at a density of 5×104 cells/mL was seeded per well and allowed to attach to a 96-well plate for 24 h at 37 °C in a humidified incubator with 5% CO2. For IVM, 10 L of twofold dilutions was added to each well to a final concentration of 12.5 M to 500 M in triplicate, while for DA, AQ, and CF, 10 L of twofold dilutions was added to each well, to a final concentration of 100 M in triplicate. Wells with only a culture medium were used as blanks, while wells containing cells and a medium with 0.4% DMSO were used as a positive control. Subsequently, the plate was incubated for another 24 h. Ten microliters of Cell Counting Kit-8 was added, and the plate was further incubated for 3 h the absorbance was then measured at 450 nm using a microplate reader.

What Is Post Treatment Lyme Disease

Post Treatment Lyme Disease represents a research subset of patients who remain significantly ill 6 months or more following standard antibiotic therapy for Lyme disease. PTLD is characterized by a constellation of symptoms that includes severe fatigue, musculoskeletal pain, sleep disturbance, depression, and cognitive problems such as difficulty with short-term memory, speed of thinking, or multi-tasking. In the absence of a direct diagnostic biomarker blood test, PTLD has been difficult to define by physicians, and its existence has been controversial. However, our clinical research shows that meticulous patient evaluation when used alongside appropriate diagnostic testing can reliably identify patients with a history of previously treated Lyme disease who display the typical symptom patterns of PTLD.

Don’t Miss: Is There A Test For Lyme Disease

Lyme Disease Ayuda A La Organizacion Mundial De La Salud

IVE DONE A COUPLE OF BLOGS IN SPANISH, THIS IS ONE OF THOSE, ASKING THE WORLD HEALTH ORGANIZATION TO HELP US PEOPLE WITH LYME DISEASE. Si no son ustedes, entonces ahora quien podra ayudarnos? Como tengo Lyme Disease, Babesia, Bartonella y otras co-infecciones le escribi pidiendo ayuda a unos medicos

What Are The Risk Factors For Post Treatment Lyme Disease

Risk factors for Post Treatment Lyme Disease include:

• Delay in diagnosis
• Increased severity of initial illness
• Presence of neurologic symptoms

Increased severity of initial illness, the presence of neurologic symptoms, and initial misdiagnosis increase the risk of Post Treatment Lyme Disease. PTLD is especially common in people that have had neurologic involvement. The rates of Post Treatment Lyme Disease after neurologic involvement may be as high as 20% or even higher. Other risk factors being investigated are genetic predispositions and immunologic variables.

In addition to Borrelia burgdorferi, the bacteria that causes Lyme disease, there are several other tick-borne co-infections that may also contribute to more prolonged and complicated illness.

Read Also: What Does A Lyme Tick Look Like

Repurposing Drugs For Covid

Not every attempt at repurposing a drug works as hoped, however.

At the start of the pandemic, scientists and doctors tried to find inexpensive medications to repurpose for the treatment and prevention of COVID-19. Chloroquine and hydroxychloroquine were two of those drugs. They were chosen because of possible antiviral effects documented in laboratory studies and limited anecdotal case reports from the first COVID-19 outbreaks in China. However, large clinical studies of these drugs to treat COVID-19 did not translate to any meaningful benefits. This was partly due to the serious toxic effects patients experienced before the drugs reached a high enough dose to inhibit or kill the virus.

Unfortunately, lessons from these failed attempts have not been applied to ivermectin. The false hope around using ivermectin to treat COVID-19 originated from an in Australia. Although the results from this study were widely circulated, I immediately had serious doubts. The concentration of ivermectin they tested was 20 to 2,000 times higher than the standard dosages used to treat human parasitic infections. Indeed, many other pharmaceutical experts confirmed my initialconcerns within a month of the papers publication. Such high concentrations of the drug could be significantly toxic.

Lyme The Medical Political Fight Of The Century

It wont resolve fast it will be slow and painful like Lyme Disease does! The question is why the Medical Board is neglecting the pain and suffering of thousands of people by providing insufficient and inappropriate treatment? Why these big powerful people in the medical area ignore the calling of

Read Also: How Do You Know If You Get Lyme Disease

Borrelia Mayonii Spirochetes Observed On Blood Smear

B. mayonii is a relatively new species of Lyme causing pathogen that has only been detected in the Upper Midwest of the United States. It is considered a rare cause of Lyme disease and may frequently go undetected.

Mayo laboratories recently observed that spirochetes of the pathogen Borrelia mayonii can occasionally be visualized on routine blood smears, much like spirochetes of the Tick-Borne Relapsing Fever group. B. mayonii spirochetes are found at high levels in peripheral blood, whereas B. burgdorferi spirochetes are not. This understanding may raise awareness and recognition of the Lyme disease causing bacterium, and could lead to more consistent and accurate diagnosis of this cause of Lyme disease.

Read full article here

Lyme Disease Is A Parasitic Infection Graphic Kathy Tagudin

Borrelia Burgdorferi is a small PARASITE, transmitted by a tick, that initially invades the blood of the human and from there it travels to different organs and tissues of the host. Borrelia is a parasitic infection not just abacterial infection, unless bacteria is looked at as a small parasite. I

Recommended Reading: What Helps Lyme Disease Symptoms

Scientists Find Promising New Treatment For Lyme Disease

A new study gives hope that an effective treatment for Lyme disease may be available in the future. The new treatment involves the drugs cefotaxime and azlocillin.

The new paper appears in the Nature journal Scientific Reports .

Lyme disease affects nearly 300,000 people a year in the United States and around 230,000 people a year in Europe, according to an article in the Journal of Public Health .

Bacteria belonging to the group Borrelia burgdorferi cause Lyme disease. Most people develop it after being bitten by a tick that carries the bacteria.

Approximately 6080% of people with Lyme disease develop a circular red skin rash called erythema migrans around the infected tick bite, and some also develop flu-like symptoms.

Most people develop the rash within 4 weeks of being bitten, but it can appear up to 3 months afterward.

of people with the disease later develop symptoms of fatigue, pain in their muscles, joints or nerves, and cognitive impairment.

These symptoms can continue for months or even years after their initial infection.

Researchers have suggested that this may because of drug-tolerant persisters, a group of bacterial cells that survive the initial dose of antibiotics.

Others believe its an immune disorder caused by bacteria during the first exposure, which causes a perpetual inflammation condition. Whatever the cause, the pain for patients is still very real.

Ivermectin Is Highly Effective As A Safe Prophylaxis And Treatment For Covid

Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies. Led by the Front Line COVID-19 Critical Care Alliance , a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with ivermectin distribution efforts all showing that ivermectin is an effective prophylaxis and treatment for COVID-19.

We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin, said Pierre Kory, M.P.A., MD, president and chief medical officer of the FLCCC. We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic.

A focus of the manuscript was on the 27 controlled trials available in January 2021, 15 of which were randomized controlled trials , the preferred trial of the World Health Organization, U.S. National Institutes of Health, and the European Medicines Agency. Consistent with numerous meta-analyses of ivermectin RCTs since published by expert panels from the UK, Italy, Spain, and Japan, they found large, statistically significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with ivermectin.

Also Check: Dogs And Lyme Disease Treatment

Awareness Of Lyme Disease

1.1.1 Be aware that:

• the bacteria that cause Lyme disease are transmitted by the bite of an infected tick

• ticks are mainly found in grassy and wooded areas, including urban gardens and parks

• tick bites may not always be noticed

• infected ticks are found throughout the UK and Ireland, and although some areas appear to have a higher prevalence of infected ticks, prevalence data are incomplete

• particularly high-risk areas are the South of England and Scottish Highlands but infection can occur in many areas

• Lyme disease may be more prevalent in parts of central, eastern and northern Europe and parts of Asia, the US and Canada.

1.1.2 Be aware that most tick bites do not transmit Lyme disease and that prompt, correct removal of the tick reduces the risk of transmission.

1.1.3 Give people advice about:

• where ticks are commonly found

• the importance of prompt, correct tick removal and how to do this

• covering exposed skin and using insect repellents that protect against ticks

• how to check themselves and their children for ticks on the skin

• sources of information on Lyme disease, such as Public Health England’s resources and guidance on Lyme disease and organisations providing information and support, such as patient charities.

For a short explanation of why the committee made the recommendations and how they might affect practice, see the rationale and impact section on awareness of Lyme disease.